Pre-clinical studies to advance zilovertamab-based anti-ror1 dual specificity car t-cell therapy for metastatic prostate cancer.

JOURNAL OF UROLOGY(2023)

引用 0|浏览8
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要